PROCYSBIDelayed-release (Raptor Therapeutics Inc.)
Welcome to the PulseAid listing for the PROCYSBI drug offered from Raptor Therapeutics Inc.. This Cystine Depleting Agent [EPC],Cystine Disulfide Reduction [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Raptor Therapeutics Inc. |
| NON-PROPRIETARY NAME: | cysteamine bitartrate |
| SUBSTANCE NAME: | CYSTEAMINE BITARTRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cystine Depleting Agent [EPC],Cystine Disulfide Reduction [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE, DELAYED RELEASE PELLETS |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2013-04-30 |
| END MARKETING DATE: | 0000-00-00 |
PROCYSBI Delayed-release HUMAN PRESCRIPTION DRUG Details:
| Item Description | PROCYSBI Delayed-release from Raptor Therapeutics Inc. |
| LABELER NAME: | Raptor Therapeutics Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 25(mg/1) |
| START MARKETING DATE: | 2013-04-30 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 49663-001_3c71b268-ffe6-4693-b2eb-162f4852970a |
| PRODUCT NDC: | 49663-001 |
| APPLICATION NUMBER: | NDA203389 |
Other CYSTEAMINE BITARTRATE Pharmaceutical Manufacturers / Labelers:
